Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis

Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis

AbstractObjective The association between nutritional status and prognosis of idiopathic pulmonary fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore the effect of body mass index (BMI) and weight loss on the prognosis of IPF patients.Methods We accumulated stu...

Full description

Bibliographic Details
Main Authors:	Xing He, Jiaqi Ji, Chi Liu, Zeli Luo, Jialong Tang, Haiying Yan, Lu Guo
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Annals of Medicine
Subjects:	Idiopathic pulmonary fibrosis body mass index weight loss mortality acute exacerbation hospitalization
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2024.2311845

Similar Items

Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis
by: Margaret Neighbors, et al.
Published: (2023-06-01)

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
by: Keisuke Anan, et al.
Published: (2022-10-01)

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Yoshimasa Hachisu, et al.
Published: (2019-05-01)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
by: Elisabetta Balestro, et al.
Published: (2019-10-01)

Baseline Blood Levels of Mucin-1 Are Associated with Crucial On-Treatment Adverse Outcomes in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Pirfenidone
by: Tang-Hsiu Huang, et al.
Published: (2024-02-01)

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
by: Ioannis Tomos, et al.
Published: (2023-10-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Toru Arai, et al.
Published: (2023-11-01)

Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
by: Eunhye Bae, et al.
Published: (2022-11-01)

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
by: Tejaswini Kulkarni, et al.
Published: (2024-03-01)

Diverse echocardiographic changes in the course of hypoxia due to acute exacerbation of idiopathic pulmonary fibrosis
by: Toshimitsu Tsugu, et al.
Published: (2020-09-01)

Successful Rescue of Acute Exacerbation of Idiopathic Pulmonary Fibrosis after Surgery for Lung Cancer: Case Report
by: Chuan HUANG, et al.
Published: (2022-05-01)

Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
by: Keishi Sugino, et al.
Published: (2022-11-01)

Mechanical ventilation in patients with idiopathic pulmonary fibrosis in Korea: a nationwide cohort study
by: Jae Kyeom Sim, et al.
Published: (2024-03-01)

Sex Differences in the Incidence and Outcomes of Patients Hospitalized by Idiopathic Pulmonary Fibrosis (IPF) in Spain from 2016 to 2019
by: Belén López-Muñiz Ballesteros, et al.
Published: (2021-08-01)

End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
by: Norimichi Akiyama, et al.
Published: (2022-10-01)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
by: Mervi Kreus, et al.
Published: (2022-08-01)

The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
by: Saqib H. Baig, et al.
Published: (2024-01-01)

Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment
by: Michelle B. Herberts, et al.
Published: (2023-08-01)

Acute exacerbation of idiopathic pulmonary fibrosis model in the rats using bleomycin and lipopolysaccharides
by: Sandy Vitria Kurniawan, et al.
Published: (2023-06-01)

Idiopathic Pulmonary Fibrosis and Telomeres
by: Alba Mulet, et al.
Published: (2022-11-01)

Acute exacerbation of postoperative idiopathic pulmonary fibrosis in a patient with lung cancer caused by invasive mechanical ventilation: A case report
by: Bin Qiu, et al.
Published: (2023-11-01)

Association between weight loss and mortality in idiopathic pulmonary fibrosis
by: Aleksandr Kalininskiy, et al.
Published: (2022-12-01)

A Systematic Review of the Prognostic Significance of the Body Mass Index in Idiopathic Pulmonary Fibrosis
by: Angelo Zinellu, et al.
Published: (2023-01-01)

Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study
by: Xing He, et al.
Published: (2024-12-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
by: Swiss Medical Weekly
Published: (2003-07-01)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
by: Paolo Cameli, et al.
Published: (2022-08-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
by: Wei Yan, et al.
Published: (2015-01-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis
by: Chen Tao, et al.
Published: (2023-03-01)

The Role of Serum 1,25-Dihydroxy Vitamin D3 and PCT in Idiopathic Pulmonary Fibrosis
by: Yang L, et al.
Published: (2022-11-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

Acute exacerbation of idiopathic pulmonary fibrosis disease: a diagnosis model in China
by: Liye Meng, et al.
Published: (2024-03-01)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
by: Paola Faverio, et al.
Published: (2021-09-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
by: Belén López-Muñiz Ballesteros, et al.
Published: (2023-05-01)

Relationship between air pollution exposure and the progression of idiopathic pulmonary fibrosis in Madrid: Chronic respiratory failure, hospitalizations, and mortality. A retrospective study
by: Pablo Mariscal-Aguilar, et al.
Published: (2023-03-01)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
by: Steven D. Nathan, et al.
Published: (2024-01-01)

Small airway dysfunction in idiopathic pulmonary fibrosis
by: Chengsheng Yin, et al.
Published: (2022-10-01)

Diagnostic Approaches for Idiopathic Pulmonary Fibrosis
by: Jae Ha Lee, et al.
Published: (2024-01-01)